Skip to content

Topical anti-androgen (investigational)

METHYLPYRIDINYL FLUOROMETHOXYBENZONITRILE DIMETHYLOXOTHIOOXOIMIDAZOLIDINE

CAS 1272719-08-0
35

Safety score · 0–100

Caution

Derived from EU CosIng regulatory status, PubChem hazard data and published research. How we score.

An INCI name for KX-826 (pyrilutamide), a topical androgen receptor antagonist developed by Kintor Pharma for androgenetic hair loss and acne, with limited independent cosmetic safety data.

Skin benefits

  • Investigational topical androgen receptor antagonist (KX-826)
  • Studied for androgenetic alopecia, acne, and sebum control

Known concerns

  • Newly INCI-registered, with very limited public safety review
  • Hormonally active compound (anti-androgen) raising endocrine concern
  • No CIR or SCCS assessment available
  • Behaves more like a drug than a routine cosmetic active

References

EU

EU CosIng database

European Commission cosmetic ingredient registry: regulatory status, restrictions, authorised functions.

Check your shelf

Find METHYLPYRIDINYL FLUOROMETHOXYBENZONITRILE DIMETHYLOXOTHIOOXOIMIDAZOLIDINE in your products.

Scan any cosmetic product with LuxSense to see if it contains METHYLPYRIDINYL FLUOROMETHOXYBENZONITRILE DIMETHYLOXOTHIOOXOIMIDAZOLIDINE and get a full ingredient breakdown with safety scores.

This profile is for educational purposes and does not constitute medical advice. Regulatory status and scientific understanding evolve, so always read the physical product label and consult a healthcare professional for personal concerns.